ID4 Promotes Breast Cancer Chemotherapy Resistance via CBF1-MRP1 Pathway

Chemo-resistance is considered a key problem in triple negative breast cancer (TNBC) chemotherapy and as such, an urgent need exists to identify its exact mechanisms. Inhibitor of DNA binding factor 4 (ID4) was reported to play diverse roles in different breast cancer molecular phenotypes. In additi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xi, Gu, Guangyan, Song, Lin, Wang, Dan, Xu, Yali, Yang, Shuping, Xu, Bin, Cao, Zhixin, Liu, Chunmei, Zhao, Chunming, Zong, Yuanyuan, Qin, Yejun, Xu, Jiawen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171490/
https://www.ncbi.nlm.nih.gov/pubmed/32328189
http://dx.doi.org/10.7150/jca.31988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171490/
https://www.ncbi.nlm.nih.gov/pubmed/32328189
http://dx.doi.org/10.7150/jca.31988

Ejemplares similares